Corden Pharma

CordenPharma & pHLIP announce strategic alliance to develop pHLIP LNP targeted delivery platform for RNA & gene therapies   

4 January 2024 – Basel, Switzerland / Providence, RI, USA – CordenPharma International (Basel, Switzerland) and pHLIP, Inc. (Kingston, RI) are pleased to announce their strategic alliance to collaborate in developing and commercialising the pHLIP-LNP targeted delivery platform for RNA-based and genetic therapeutics.  The alliance will combine CordenPharma’s proprietary Lipid NanoParticle (LNP) technology and GMP...
Otto-Hahn-Straße 68723 Plankstadt Germany